ClariVest Asset Management’s Fulgent Genetics FLGT Stock Holding History

ClariVest Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,744	Closed	-$295K	–	709
2022 Q3	$295K	Sell	7,744 -23	-0.3%	-$1.15K	0.01%	411
2022 Q2	$424K	Hold	7,767	–	–	0.02%	399
2022 Q1	$485K	Buy	7,767 +2,023	+35%	+$133K	0.02%	391
2021 Q4	$578K	Buy	+5,744	New	+$505K	0.02%	414
2020 Q4	–	Sell	-15,100	Closed	-$605K	–	778
2020 Q3	$605K	Sell	15,100 -3,000	-17%	-$93.9K	0.02%	337
2020 Q2	$290K	Sell	18,100 -8,400	-32%	-$129K	0.01%	487
2020 Q1	$285K	Sell	26,500 -22,118	-45%	-$308K	0.01%	452
2019 Q4	$627K	Buy	48,618 +47,946	+7,135%	+$570K	0.01%	403
2019 Q3	$7K	Buy	+672	New	+$6.37K	﹤0.01%	549

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ClariVest Asset Management's FLGT Position: Q4 2022 in Review

ClariVest Asset Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 7,744 shares — an estimated $295K sold.

ClariVest Asset Management first reported a position in FLGT in Q3 2019 and held it in 9 quarters. The position peaked at $627K in Q4 2019. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

ClariVest Asset Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
ClariVest Asset Management sold 7,744 Fulgent Genetics shares in Q4 2022, an estimated $295K.
ClariVest Asset Management first reported a position in Fulgent Genetics in Q3 2019 and held it in 9 quarters.
ClariVest Asset Management's Fulgent Genetics position peaked at $627K in Q4 2019.
224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on ClariVest Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.